Cargando…
Retrospective, multicenter study of surgical treatment for carotid body tumors with or without preoperative embolization
BACKGROUND: Carotid body tumor (CBT) is the most common head and neck paraganglioma. Whether preoperative embolization benefits CBT patients who will receive surgical resection is still controversial. METHODS: In this multi-center retrospective study, we collected data from patients with CBT who rec...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018181/ https://www.ncbi.nlm.nih.gov/pubmed/36937387 http://dx.doi.org/10.3389/fonc.2023.1123430 |
_version_ | 1784907758408040448 |
---|---|
author | Han, Tonglei Pu, Jiaxi Tang, Hanfei Yang, Shaofei Dong, Dandan Lu, Minhao Wei, Xiaolong Yang, Guanghua Zhao, Bin Guo, Daqiao Tang, Xiao Zhao, Zhiqing |
author_facet | Han, Tonglei Pu, Jiaxi Tang, Hanfei Yang, Shaofei Dong, Dandan Lu, Minhao Wei, Xiaolong Yang, Guanghua Zhao, Bin Guo, Daqiao Tang, Xiao Zhao, Zhiqing |
author_sort | Han, Tonglei |
collection | PubMed |
description | BACKGROUND: Carotid body tumor (CBT) is the most common head and neck paraganglioma. Whether preoperative embolization benefits CBT patients who will receive surgical resection is still controversial. METHODS: In this multi-center retrospective study, we collected data from patients with CBT who received surgical treatment without (group A) or with preoperative embolization (group B) from 2011 to 2019. The primary outcome was the rate of death or stroke after 3 years of follow-up. The secondary outcomes of the study were length of operation (LOO), intraoperative blood loss (IBL), length of stay (LOS), rate of recurrence, and rate of cranial nerve (CN) injuries. Descriptive statistics were used to analyze the demographics, clinical characteristics, complications, and follow-up results of the patients. RESULTS: Between January 2011 and October 2019, 261 consecutive patients (107 male and 154 female) entered analysis. After 3 years of follow-up, no patient died in both groups. Only three patients with stroke were detected: 2/226 (0.9%) in group A vs. 1/35 (2.9%) in group B (p = .308). The LOO in group A was 132.6 ± 64.6 min compared with 152.9 ± 40.4 min in group B (p = .072). IBL in group A was 375.4 ± 497.8 ml compared with 448.0 ± 270.8 ml in group B (p = .400). LOS in group A was 8.3 ± 2.0 days compared with 7.4 ± 1.7 days in group B (p = .016). Seventy-two CN injuries were detected: 65/226 (28.8%) in group A vs. 7/35 (20.0%) in group B (p = .281). There were 65 temporary CN injuries (59 in group A vs. 6 in group B) (p = .254) and seven permanent CN injuries (6 in group A vs. 1 in group B) (p = .945). Three most frequently injured cranial nerves were the pharyngeal branch and superior laryngeal nerve (12.3%), recurrent laryngeal nerve (7.7%) and vagus nerve (7.3%). CONCLUSION: There was insufficient evidence to support the efficacy of preoperative embolization. CBT resection alone had a similar rate of stoke, recurrence, and CN injuries when compared with CBT resection with preoperative arterial embolization. Meanwhile, CBT resection alone did not increase LOO and IBL. |
format | Online Article Text |
id | pubmed-10018181 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-100181812023-03-17 Retrospective, multicenter study of surgical treatment for carotid body tumors with or without preoperative embolization Han, Tonglei Pu, Jiaxi Tang, Hanfei Yang, Shaofei Dong, Dandan Lu, Minhao Wei, Xiaolong Yang, Guanghua Zhao, Bin Guo, Daqiao Tang, Xiao Zhao, Zhiqing Front Oncol Oncology BACKGROUND: Carotid body tumor (CBT) is the most common head and neck paraganglioma. Whether preoperative embolization benefits CBT patients who will receive surgical resection is still controversial. METHODS: In this multi-center retrospective study, we collected data from patients with CBT who received surgical treatment without (group A) or with preoperative embolization (group B) from 2011 to 2019. The primary outcome was the rate of death or stroke after 3 years of follow-up. The secondary outcomes of the study were length of operation (LOO), intraoperative blood loss (IBL), length of stay (LOS), rate of recurrence, and rate of cranial nerve (CN) injuries. Descriptive statistics were used to analyze the demographics, clinical characteristics, complications, and follow-up results of the patients. RESULTS: Between January 2011 and October 2019, 261 consecutive patients (107 male and 154 female) entered analysis. After 3 years of follow-up, no patient died in both groups. Only three patients with stroke were detected: 2/226 (0.9%) in group A vs. 1/35 (2.9%) in group B (p = .308). The LOO in group A was 132.6 ± 64.6 min compared with 152.9 ± 40.4 min in group B (p = .072). IBL in group A was 375.4 ± 497.8 ml compared with 448.0 ± 270.8 ml in group B (p = .400). LOS in group A was 8.3 ± 2.0 days compared with 7.4 ± 1.7 days in group B (p = .016). Seventy-two CN injuries were detected: 65/226 (28.8%) in group A vs. 7/35 (20.0%) in group B (p = .281). There were 65 temporary CN injuries (59 in group A vs. 6 in group B) (p = .254) and seven permanent CN injuries (6 in group A vs. 1 in group B) (p = .945). Three most frequently injured cranial nerves were the pharyngeal branch and superior laryngeal nerve (12.3%), recurrent laryngeal nerve (7.7%) and vagus nerve (7.3%). CONCLUSION: There was insufficient evidence to support the efficacy of preoperative embolization. CBT resection alone had a similar rate of stoke, recurrence, and CN injuries when compared with CBT resection with preoperative arterial embolization. Meanwhile, CBT resection alone did not increase LOO and IBL. Frontiers Media S.A. 2023-03-02 /pmc/articles/PMC10018181/ /pubmed/36937387 http://dx.doi.org/10.3389/fonc.2023.1123430 Text en Copyright © 2023 Han, Pu, Tang, Yang, Dong, Lu, Wei, Yang, Zhao, Guo, Tang and Zhao https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Han, Tonglei Pu, Jiaxi Tang, Hanfei Yang, Shaofei Dong, Dandan Lu, Minhao Wei, Xiaolong Yang, Guanghua Zhao, Bin Guo, Daqiao Tang, Xiao Zhao, Zhiqing Retrospective, multicenter study of surgical treatment for carotid body tumors with or without preoperative embolization |
title | Retrospective, multicenter study of surgical treatment for carotid body tumors with or without preoperative embolization |
title_full | Retrospective, multicenter study of surgical treatment for carotid body tumors with or without preoperative embolization |
title_fullStr | Retrospective, multicenter study of surgical treatment for carotid body tumors with or without preoperative embolization |
title_full_unstemmed | Retrospective, multicenter study of surgical treatment for carotid body tumors with or without preoperative embolization |
title_short | Retrospective, multicenter study of surgical treatment for carotid body tumors with or without preoperative embolization |
title_sort | retrospective, multicenter study of surgical treatment for carotid body tumors with or without preoperative embolization |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018181/ https://www.ncbi.nlm.nih.gov/pubmed/36937387 http://dx.doi.org/10.3389/fonc.2023.1123430 |
work_keys_str_mv | AT hantonglei retrospectivemulticenterstudyofsurgicaltreatmentforcarotidbodytumorswithorwithoutpreoperativeembolization AT pujiaxi retrospectivemulticenterstudyofsurgicaltreatmentforcarotidbodytumorswithorwithoutpreoperativeembolization AT tanghanfei retrospectivemulticenterstudyofsurgicaltreatmentforcarotidbodytumorswithorwithoutpreoperativeembolization AT yangshaofei retrospectivemulticenterstudyofsurgicaltreatmentforcarotidbodytumorswithorwithoutpreoperativeembolization AT dongdandan retrospectivemulticenterstudyofsurgicaltreatmentforcarotidbodytumorswithorwithoutpreoperativeembolization AT luminhao retrospectivemulticenterstudyofsurgicaltreatmentforcarotidbodytumorswithorwithoutpreoperativeembolization AT weixiaolong retrospectivemulticenterstudyofsurgicaltreatmentforcarotidbodytumorswithorwithoutpreoperativeembolization AT yangguanghua retrospectivemulticenterstudyofsurgicaltreatmentforcarotidbodytumorswithorwithoutpreoperativeembolization AT zhaobin retrospectivemulticenterstudyofsurgicaltreatmentforcarotidbodytumorswithorwithoutpreoperativeembolization AT guodaqiao retrospectivemulticenterstudyofsurgicaltreatmentforcarotidbodytumorswithorwithoutpreoperativeembolization AT tangxiao retrospectivemulticenterstudyofsurgicaltreatmentforcarotidbodytumorswithorwithoutpreoperativeembolization AT zhaozhiqing retrospectivemulticenterstudyofsurgicaltreatmentforcarotidbodytumorswithorwithoutpreoperativeembolization |